Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Worldwide Clinical Trials founder honoured with European CEO award
Worldwide Clinical Trials founder honoured with European CEO award
Neal Cutler recognised as Best CEO in the CRO Industry for his leadership in pivotal clinical trials and success as a clinical researcher
BioreclamationIVT appoints Senior Marketing Communications Manager
BioreclamationIVT appoints Senior Marketing Communications Manager
Pharmalink appoints new Chief Executive Officer
Pharmalink appoints new Chief Executive Officer
Lauren P. Silvernail appointed to Nicox Board of Directors
Lauren P. Silvernail appointed to Nicox Board of Directors
Renewal of the terms of office of Birgit Stattin Norinder and Michele Garufi
Elligo Health names CDISC founder as new Scientific Innovation Officer
Elligo Health names CDISC founder as new Scientific Innovation Officer
New Chair of BCAS low pressure and vacuum group
New Chair of BCAS low pressure and vacuum group
Gardner Denver representative appointed to British Compressed Air Society’s group
CellGenix appoints leading experts to Scientific Advisory Board
CellGenix appoints leading experts to Scientific Advisory Board
Cliona Rooney, Mitchell H. Finer and Anthony Davies
Certara appoints Sandy Allerheiligen as Senior VP of Health Economics and Education
Certara appoints Sandy Allerheiligen as Senior VP of Health Economics and Education
Allerheiligen will use her model-informed drug development expertise to support Certara’s work in quantifying a drug’s value to patients
Cerecor appoints Steven Boyd and Peter Greenleaf to Board of Directors
Cerecor appoints Steven Boyd and Peter Greenleaf to Board of Directors
GW Pharmaceuticals R&D Management appointments
GW Pharmaceuticals R&D Management appointments
Volker Knappertz appointed Chief Medical Officer and Professor Ben Whalley to join as Head of Discovery Research
Abbas Hussain joins the Board of Immunocore as Non-Executive Director
Abbas Hussain joins the Board of Immunocore as Non-Executive Director
Ian Clark also appointed as special adviser to the Board
Macrophage Pharma appoints Development Director
Macrophage Pharma appoints Development Director
Joanne Bedwell-Garner joins management team
Biocartis announces its new CEO
Biocartis announces its new CEO
WIRB-Copernicus Group acquires MedAvante and ProPhase
WIRB-Copernicus Group acquires MedAvante and ProPhase
Names Jeffrey Litwin as the Chief Executive Officer (CEO) of the combined company
Chiesi USA makes two key leadership appointments
Chiesi USA makes two key leadership appointments
Doug Baratta and Donna White promoted to Vice President
Kymab appoints Sonia Quaratino as Chief Medical Officer
Kymab appoints Sonia Quaratino as Chief Medical Officer
Previous
1
…
75
76
77
78
(current)
79
80
81
…
213
Next
Trending Articles
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Servomex appoints new Global Sales Director
Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all